CRC
Clinical trials for CRC explained in plain language.
Never miss a new study
Get alerted when new CRC trials appear
Sign up with your email to follow new studies for CRC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for Tough-to-Treat cancers
Disease control CompletedThis study tested a new drug, CFT1946, for people with advanced solid tumors that have a specific genetic change called BRAF V600. The main goals were to find a safe dose and see if the drug, given alone or with other medications, could help control the cancer. It involved 89 adu…
Matched conditions: CRC
Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New pill targets 'Undruggable' cancer mutation in early human trial
Disease control CompletedThis early-stage study tested a new oral drug, JAB-21822, in adults with advanced solid tumors (like lung or colon cancer) that have a specific genetic change called KRAS G12C. The main goals were to find a safe dose and see if the drug, given alone or with another cancer drug (c…
Matched conditions: CRC
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC